A new study published in the Proceedings of the National Academy of Sciences presents a blood-based proteomic signature that predicts how long people are likely to live in good health—known as healthspan. The Healthspan Proteomic Score (HPS), developed by researchers at the UConn School of Medicine and collaborators at the University of Helsinki and the University of Exeter (UK), provides a powerful tool for understanding biological aging and assessing risks for a wide range of chronic diseases.
New blood-based proteomic score predicts healthspan and disease risk
-
HighlightsFree Dark Web Monitoring Stamps the $17 Million Credentials Markets
-
HighlightsSmart buildings: What happens to our free will when tech makes choices for us?
-
AppsScreenshots have generated new forms of storytelling, from Twitter fan fiction to desktop film
-
HighlightsDarknet markets generate millions in revenue selling stolen personal data, supply chain study finds
-
SecurityPrivacy violations undermine the trustworthiness of the Tim Hortons brand
-
Featured HeadlinesWhy Tesla’s Autopilot crashes spurred the feds to investigate driver-assist technologies – and what that means for the future of self-driving cars
